ICON Public Limited Company (ICLR) ist ein börsennotiertes Unternehmen im Gesundheitswesen Sektor, tätig in der Medical - Diagnostics & Research Branche. Der Hauptsitz des Unternehmens ist in Dublin, Ireland. Der aktuelle CEO ist Barry Balfe.
ICLR hat IPO-Datum 1998-05-15, 41,250 Vollzeitbeschäftigte, gelistet an der NASDAQ Global Select, eine Marktkapitalisierung von $8.63B.
ICON Public Limited Company is a clinical research organization headquartered in Dublin, Ireland, that provides comprehensive outsourced development and commercialization services to the pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. The company specializes in managing the full spectrum of clinical development from compound selection through Phase I-IV clinical studies, offering services including early-stage development, patient recruitment, data management, biostatistics, medical writing, regulatory strategy, and pharmacovigilance. With a global presence across Ireland, Europe, the United States, and internationally, ICON delivers integrated solutions encompassing clinical development, medical imaging, laboratory services, site monitoring, and consulting and analytics support. Founded in 1990, the company has established itself as a key partner in accelerating drug development and bringing new therapeutics to market.
